With the Eversense 90-Day CGM System, you can actively manage your diabetes simply and with confidence. The Eversense CGM System provides continuous glucose monitoring for up to 90 days via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. If you're on insulin, discover what Eversense can do for you.

Eversense CGM System Sets a New Standard

Improve Diabetes Management

Helps to support better diabetes management.

Pills Icon

Accuracy unaffected when taking Tylenol (Acetaminophen) and/or Vitamin C.2

Radar Icon

Detects 95% of hypoglycemic and 99% of hyperglycemic events.3

Blood Cells Icon

Shown to significantly reduce A1c by 0.5%.1

Device Icon

Transmitter can be removed and replaced without wasting the sensor.

Eversense Sets a New Standard

 

Helps to support better diabetes management.
 

 

Accuracy unaffected when taking Tylenol (Acetaminophen) and/or Vitamin C.2

 

Detects 95% of hypoglycemic and 99% of hyperglycemic events.3

 

Shown to significantly reduce A1c by 0.5%.1
 

 

Transmitter can be removed and replaced without wasting the sensor.

Sensor Thumbnail

Sensor

Professionally inserted by a
Health Care Provider.




Remains accurate, even if you sleep on it or while you exercise.1 


Rests comfortably just under the skin.

LEARN MORE
Transmitter Thumbnail

Transmitter

Removable, rechargeable and water resistant.

Water resistant when submerged in 1 meter of water for up to 30 minutes.


Sends data every 5 minutes to your mobile device.


Provides on-body alerts so you don't always have to have your mobile device nearby.

LEARN MORE
Mobile App Thumbnail

Mobile App

Receive real-time glucose measurements on your compatible mobile phone or smart watch. No need for a separate receiver.



Track events like meals and workouts and show them right on your graph to help identify trends.


Share your data with friends, family and your Health Care Provider.

LEARN MORE

Get started with Eversense CGM System

If you're on multiple daily doses of insulin, you might greatly benefit from Eversense. Complete the form below so we can tell you more about Eversense and check your eligibility and coverage. An Ascensia Diabetes Care representative will be in touch shortly.

Plus! Savings of up to $300 toward out-of-pocket cost for each Eversense 90-day sensor and transmitter (up to $1200) may be available for eligible patients.

Learn more

*Field is required



 

The sensor placement went very well. I felt nothing, no pain, no discomfort. There are no stitches, no sutures, just two steri strips and a bandage.

Robert, Eversense CGM User

See why Robert loves Eversense*

* The individual in this video has been sponsored by Senseonics to appear in the video. The opinions expressed belong solely to the individual. This information provides general information only. It is not intended to be used as medical advice, diagnosis or treatment and should not replace the advice of a Health Care Provider. A Health Care Provider must be consulted and the device user manual reviewed in full before use. Individual results may vary, testimonials are not claimed to represent typical results. All testimonials are not intended to represent or guarantee that anyone will achieve the same or similar results

† Indicated for up to 90 days

‡ Limitations and restrictions apply. Eligible patients with U.S. commercial health insurance may receive up to $300 US dollars towards out-of-pocket costs per Eversense 90 day sensor and transmitter for up to 1 year from the date of initial service request. Void where prohibited, including Massachusetts. Ascensia Diabetes Care reserves the right to terminate the program at any time without notice.

  1. Christiansen MP, Klaff LJ, Brazg R, et al. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. Diabetes Technology & Therapeutics. 2018; 20(3): 197–206
  2. Lorenz C, Sandoval W, Mortellaro M. Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System. Diabetes Technology and Therapeutics. 2018; 20(5): 344-352. DOI: 10.1089/dia.2018.0028
  3. Christiansen MP, KlaffLJ, Bailey TS, Brazg R, Carlson G, Tweden KS. A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study. Diabetes Technology & Therapeutics. 2019; 21(5): 231 -237. doi:10.1089/dia.2019.0020.

The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by Ascensia Diabetes Care is under license.